Principles, Testing Procedures, Culture Media Selection, and Applications in Sterile Pharmaceutical Quality Control
1. Introduction
In the pharmaceutical industry, sterility assurance is a critical quality requirement for products intended to be sterile, including injectable drugs, infusion solutions, ophthalmic preparations, and certain biological products.
The presence of viable microorganisms in these products may cause infections, compromise patient safety, and result in failure to meet pharmacopoeial quality requirements.
Sterility testing is a microbiological test designed to detect the presence of viable microorganisms capable of growing under specified test conditions.
Two conventional methods are recognized by major pharmacopoeias:
Membrane Filtration Method: Microorganisms are retained on a membrane filter and subsequently incubated in suitable culture media.
Direct Inoculation Method: The test product is directly introduced into appropriate culture media.
Membrane filtration is generally preferred when the nature of the product permits, particularly for filterable liquid pharmaceutical preparations.
This method allows microorganisms to be separated from much of the product matrix. The membrane can also be rinsed to reduce the inhibitory effects of antimicrobial substances.
2. Applicable Standards and Regulatory Requirements
USP <71>, Ph. Eur. 2.6.1, and the corresponding Japanese Pharmacopoeia methods have been harmonized in specified areas through the Pharmacopeial Discussion Group (PDG).
ISO 11737-2 primarily addresses sterility testing used to establish, validate, and maintain sterilization processes for health care products, particularly medical devices.
It does not replace USP <71> or Ph. Eur. 2.6.1 for routine pharmaceutical batch-release sterility testing.
3. Principle of the Membrane Filtration Method
The membrane filtration method is based on retaining microorganisms present in a test sample on a sterile membrane filter.
The sample is passed through a membrane with a nominal pore size not greater than 0.45 µm and a demonstrated ability to retain microorganisms.
Following filtration, the membrane may be rinsed with a suitable sterile solution to remove or reduce substances that could inhibit microbial growth.
The membrane is then transferred into culture media or brought into contact with the media within a suitable closed sterility testing system.
Two commonly used culture media are:
Fluid Thioglycollate Medium (FTM).
Soybean-Casein Digest Medium (SCDM), also commonly referred to as Tryptic Soy Broth (TSB).
The media are incubated under specified conditions to detect microbial growth.
Advantages of Membrane Filtration
Suitable for many filterable liquid pharmaceutical products.
Allows relatively large sample volumes to be tested.
Facilitates removal of antimicrobial substances through membrane rinsing.
Can be performed using closed filtration systems to minimize contamination risks.
Supports sterility testing in accordance with major pharmacopoeial requirements.
However, method suitability must be demonstrated for each relevant product and testing procedure.
4. Culture Media Used in Sterility Testing
4.1. Fluid Thioglycollate Medium (FTM)
Fluid Thioglycollate Medium is used in sterility testing to support the growth of various bacteria, particularly anaerobic microorganisms.
Its formulation contains reducing agents that help establish suitable oxidation-reduction conditions for microbial growth.
Some FTM formulations contain resazurin as an oxidation-reduction indicator.
Typical incubation conditions:
Temperature: 30–35°C.
Duration: Not less than 14 days.
Before use, the medium must meet the applicable requirements for sterility and growth-promoting properties.
4.2. Soybean-Casein Digest Medium (SCDM/TSB)
Soybean-Casein Digest Medium is a nutrient-rich medium that supports the growth of many aerobic bacteria, yeasts, and molds.
It is commonly used alongside FTM to broaden the range of microorganisms that can be detected during sterility testing.
Typical incubation conditions:
Temperature: 20–25°C.
Duration: Not less than 14 days.
4.3. Comparison of Sterility Testing Media
The combined use of both media broadens the range of microorganisms that may be detected under the specified test conditions.
5. Dilution and Membrane Rinsing Fluids for Sterility Testing
In addition to culture media, dilution and rinsing fluids play an important role in sample preparation and membrane filtration.
5.1. Fluid A
Fluid A is one of the fluids used in pharmacopoeial membrane filtration procedures.
Typical applications may include:
Pre-wetting membrane filters.
Diluting certain pharmaceutical preparations before filtration.
Rinsing membranes to reduce residual product components.
Fluid A is commonly used for aqueous pharmaceutical preparations when compatible with the validated testing method.
5.2. Fluid D
Fluid D is used in certain membrane filtration applications, particularly where additional wetting or dispersing properties are required.
Depending on the applicable pharmacopoeial formulation and procedure, it may be suitable for preparations containing oils or other difficult-to-wet components.
Selection must be based on compatibility with the pharmaceutical product, membrane filter, and testing method.
5.3. Fluid K
Fluid K is used in certain specialized sample preparation and membrane rinsing procedures, including applications involving oily or difficult-to-disperse preparations.
Fluid A, Fluid D, and Fluid K should not be considered interchangeable without appropriate method suitability assessment.
5.4. Selection of Rinsing Fluids
No single rinsing fluid is suitable for all pharmaceutical formulations.
6. Sterility Testing Procedure Using Membrane Filtration
The general workflow consists of the following steps.
Step 1 – Preparation of Equipment and Culture Media
Prepare the following materials:
Sterile membrane filtration system, either closed or suitably configured.
Sterile membrane filters with a nominal pore size not greater than 0.45 µm.
Fluid Thioglycollate Medium (FTM).
Soybean-Casein Digest Medium (SCDM).
Appropriate dilution or membrane rinsing fluids.
Microbiological incubators.
Sterile sampling and transfer devices.
Testing must be performed under controlled aseptic conditions with appropriate contamination prevention measures.
Step 2 – Product Sampling
Collect the required number of product units and test quantities according to the applicable product monograph, USP <71>, or Ph. Eur. 2.6.1.
Sampling requirements depend on the pharmaceutical product, batch size, and volume or mass per container.
Step 3 – Membrane Filtration
Aseptically transfer the test sample into the membrane filtration system.
Pass the sample through the selected membrane filter, which must be suitable for the product and analytical method.
Microorganisms present in the sample are retained on the membrane when the filtration system performs as intended.
Step 4 – Membrane Rinsing
When necessary, rinse the membrane with a suitable sterile fluid to reduce or remove substances that may inhibit microbial growth.
The number of rinsing cycles and rinsing volume must be determined according to pharmacopoeial requirements and method suitability results.
Rinsing volumes or cycles should not be increased arbitrarily because excessive rinsing may affect microbial recovery.
Step 5 – Transfer to Culture Media
Transfer the membrane filters into FTM and SCDM, or introduce the media into the corresponding chambers of a suitable closed filtration system.
Separate membranes or other pharmacopoeially accepted arrangements may be used according to the validated procedure.
Step 6 – Incubation
Observe the culture media during incubation for evidence of microbial growth.
Step 7 – Interpretation of Results
Examine the culture media for:
Turbidity.
Sediment or visible microbial growth.
Surface films or other signs potentially associated with microbial proliferation.
If no microbial growth is observed during the specified incubation period and all validity requirements are met, the result is evaluated according to the applicable pharmacopoeial criteria.
If microbial growth is detected, further evaluation, microbial identification, and investigation must be conducted in accordance with the laboratory's quality procedures.
A positive result must not automatically be invalidated solely because contamination during testing is suspected.
7. Quality Control of Sterility Testing Media
7.1. Growth Promotion Test (GPT)
The Growth Promotion Test demonstrates that the culture medium can support the growth of specified challenge microorganisms.
Microorganisms commonly used in USP <71> growth promotion testing include:
The challenge strains, inoculum levels, and acceptance criteria must comply with the applicable current pharmacopoeial requirements.
7.2. Method Suitability Test
The Method Suitability Test demonstrates that the sterility testing procedure can detect microorganisms in the presence of the pharmaceutical product.
This is particularly important for:
Antibiotic formulations.
Preserved pharmaceutical products.
Products containing antimicrobial ingredients.
Highly viscous formulations.
Oily or poorly soluble preparations.
If the product inhibits microbial growth, suitable corrective measures such as dilution, membrane rinsing, or validated neutralization must be applied.
7.3. Sterility and Quality Control of Culture Media
Sterility testing media must be controlled for:
Sterility.
Growth-promoting properties.
Appropriate physicochemical characteristics.
Storage conditions.
Expiration date.
Batch traceability.
8. Applications in Pharmaceutical Manufacturing
8.1. Injectable Pharmaceuticals
Injectable solutions, infusion preparations, and certain reconstituted pharmaceutical products may be tested using membrane filtration when their characteristics permit.
8.2. Infusion Solutions
Products such as 0.9% Sodium Chloride Injection, 5% Glucose Infusion, and other intravenous solutions may be suitable for membrane filtration, depending on their monographs and demonstrated method suitability.
8.3. Sterile Ophthalmic Products
Sterile ophthalmic preparations may be tested using membrane filtration.
For products containing preservatives, method suitability assessment is especially important to ensure that antimicrobial activity does not interfere with microbial detection.
8.4. Biological and Biotechnology Products
Certain biological products may be tested by membrane filtration when their characteristics and analytical procedures permit.
For specialized or short-shelf-life products, alternative microbiological methods may require appropriate validation and regulatory acceptance.
9. Relationship Between Sterility Testing and EU GMP Annex 1
EU GMP Annex 1 emphasizes that sterility assurance must be achieved through a comprehensive manufacturing and contamination control system.
Finished-product sterility testing is only one component of sterility assurance and cannot replace:
Sterilization process validation.
Aseptic process validation.
Cleanroom environmental control.
Microbiological environmental monitoring.
Raw material and component control.
Contamination risk assessment.
Contamination Control Strategy (CCS).
The use of high-quality sterility testing media supports pharmaceutical quality control but does not independently guarantee product sterility.
10. LABone Solutions for Pharmaceutical Sterility Testing
LABone provides microbiological culture media, dilution fluids, and laboratory consumables supporting sterility testing applications in the pharmaceutical industry.
Fluid Thioglycollate Medium (FTM)
A culture medium designed to support the detection of bacteria, particularly anaerobic microorganisms, during sterility testing.
Soybean-Casein Digest Medium (SCDM/TSB)
A nutrient-rich culture medium supporting the detection of aerobic bacteria, yeasts, and molds.
Fluid A – Membrane Filtration Rinsing Solution
A sterile fluid used for sample dilution and membrane rinsing in appropriate sterility testing applications.
Fluid D and Fluid K
Specialized fluids supporting sample preparation and membrane rinsing for selected pharmaceutical formulations according to the applicable testing method.
Ready-to-Use Sterility Testing Solutions
Ready-to-use culture media and sterile rinsing solutions help laboratories reduce preparation steps, standardize workflows, and improve batch traceability.
Product selection should be based on the applicable pharmacopoeial method, product specifications, batch quality documentation, and demonstrated suitability for the intended application.
Explore LABone's Sterility Testing Products:
Ready-to-Use Sterility Testing Media – LABone
11. Conclusion
Sterility testing by membrane filtration is an important microbiological quality control method for pharmaceutical products required to be sterile.
Compliance with USP <71> and Ph. Eur. 2.6.1 helps standardize testing procedures, culture media requirements, incubation conditions, and result interpretation.
Fluid Thioglycollate Medium and Soybean-Casein Digest Medium play central roles in microbial detection, while rinsing fluids such as Fluid A, Fluid D, and Fluid K support sample preparation and membrane rinsing in specific applications.
Selecting appropriate culture media, rinsing fluids, and filtration systems, together with method suitability testing, media quality control, and GMP-compliant practices, contributes to the reliability of pharmaceutical sterility testing.
LABone – Advancing Microbiology Solutions.
References
United States Pharmacopeia (USP), General Chapter <71> – Sterility Tests.
European Pharmacopoeia (Ph. Eur.), Chapter 2.6.1 – Sterility.
Japanese Pharmacopoeia – Sterility Test.
EU GMP Annex 1 – Manufacture of Sterile Medicinal Products.
ISO 14644-1 – Cleanrooms and associated controlled environments — Classification of air cleanliness by particle concentration.
ISO 11737-2:2019 – Sterilization of health care products — Microbiological methods — Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process.